These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33016150)

  • 1. Lactic acid, neuron-specific enolase, and blood-brain barrier index after a severe traumatic brain injury: a prospective study.
    Lu W; Jiang C; Wang Z; Chen Y; Bai R; Yan G; Wang G; Ren H
    Br J Neurosurg; 2024 Apr; 38(2):220-224. PubMed ID: 33016150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid biomarkers versus glasgow coma scale and glasgow outcome scale in pediatric traumatic brain injury: the role of young age and inflicted injury.
    Shore PM; Berger RP; Varma S; Janesko KL; Wisniewski SR; Clark RS; Adelson PD; Thomas NJ; Lai YC; Bayir H; Kochanek PM
    J Neurotrauma; 2007 Jan; 24(1):75-86. PubMed ID: 17263671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury.
    Park SH; Hwang SK
    World Neurosurg; 2018 Oct; 118():e534-e542. PubMed ID: 30257306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CSF biomarkers and secondary insults following severe traumatic brain injury.
    Stein DM; Kufera JA; Lindell A; Murdock KR; Menaker J; Bochicchio GV; Aarabi B; Scalea TM
    Neurocrit Care; 2011 Apr; 14(2):200-7. PubMed ID: 21210304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children.
    Berger RP; Pierce MC; Wisniewski SR; Adelson PD; Clark RS; Ruppel RA; Kochanek PM
    Pediatrics; 2002 Feb; 109(2):E31. PubMed ID: 11826241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Blood-Brain Barrier Integrity on Brain Protein Biomarker Clearance in Severe Traumatic Brain Injury: A Longitudinal Prospective Study.
    Lindblad C; Nelson DW; Zeiler FA; Ercole A; Ghatan PH; von Horn H; Risling M; Svensson M; Agoston DV; Bellander BM; Thelin EP
    J Neurotrauma; 2020 Jun; 37(12):1381-1391. PubMed ID: 32013731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuron-specific enolase as an aid to outcome prediction in head injury.
    Ross SA; Cunningham RT; Johnston CF; Rowlands BJ
    Br J Neurosurg; 1996 Oct; 10(5):471-6. PubMed ID: 8922706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-traumatic hypoxia is associated with prolonged cerebral cytokine production, higher serum biomarker levels, and poor outcome in patients with severe traumatic brain injury.
    Yan EB; Satgunaseelan L; Paul E; Bye N; Nguyen P; Agyapomaa D; Kossmann T; Rosenfeld JV; Morganti-Kossmann MC
    J Neurotrauma; 2014 Apr; 31(7):618-29. PubMed ID: 24279428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
    Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS
    J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of neuron-specific enolase in head trauma patients.
    Meric E; Gunduz A; Turedi S; Cakir E; Yandi M
    J Emerg Med; 2010 Apr; 38(3):297-301. PubMed ID: 18499387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial measurement of S100B and NSE in pediatric traumatic brain injury.
    Park DW; Park SH; Hwang SK
    Childs Nerv Syst; 2019 Feb; 35(2):343-348. PubMed ID: 30171330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of Severe Traumatic Brain Injury Outcomes in Children.
    Meshcheryakov SV; Semenova ZB; Lukianov VI; Sorokina EG; Karaseva OV
    Acta Neurochir Suppl; 2018; 126():11-16. PubMed ID: 29492523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Neurocognitive Outcome after Moderate-Severe Traumatic Brain Injury Using Serum Neuron-Specific Enolase and S100 biomarkers.
    Slavoaca D; Birle C; Stan A; Tatomir A; Popa O; Rosu P; Vulcan AM; Chira D; Livint Popa L; Dina C; Vacaras V; Strilciuc S; Vos P
    J Med Life; 2020; 13(3):306-313. PubMed ID: 33072201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity.
    Thelin EP; Jeppsson E; Frostell A; Svensson M; Mondello S; Bellander BM; Nelson DW
    Crit Care; 2016 Sep; 20():285. PubMed ID: 27604350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury.
    Böhmer AE; Oses JP; Schmidt AP; Perón CS; Krebs CL; Oppitz PP; D'Avila TT; Souza DO; Portela LV; Stefani MA
    Neurosurgery; 2011 Jun; 68(6):1624-30; discussion 1630-1. PubMed ID: 21368691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Memantine on Serum Levels of Neuron-Specific Enolase and on the Glasgow Coma Scale in Patients With Moderate Traumatic Brain Injury.
    Mokhtari M; Nayeb-Aghaei H; Kouchek M; Miri MM; Goharani R; Amoozandeh A; Akhavan Salamat S; Sistanizad M
    J Clin Pharmacol; 2018 Jan; 58(1):42-47. PubMed ID: 28724200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biomarkers in children with traumatic brain injury].
    Pinelis VG; Sorokina EG; Semenova JB; Karaseva OV; Mescheryakov SV; Chernisheva TA; Arsenieva EN; Roshal LM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):66-72. PubMed ID: 26356618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood-brain barrier disruption and outcome prediction following severe traumatic brain injury: a prospective, observational study.
    Lindblad C; Pin E; Just D; Al Nimer F; Nilsson P; Bellander BM; Svensson M; Piehl F; Thelin EP
    Crit Care; 2021 Mar; 25(1):103. PubMed ID: 33712077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of β-amyloid oligomers as a predictor of neurological outcome after brain injury.
    Gatson JW; Warren V; Abdelfattah K; Wolf S; Hynan LS; Moore C; Diaz-Arrastia R; Minei JP; Madden C; Wigginton JG
    J Neurosurg; 2013 Jun; 118(6):1336-42. PubMed ID: 23540266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-mortem biochemistry of NSE and S100B: A supplemental tool for detecting a lethal traumatic brain injury?
    Sieber M; Dreßler J; Franke H; Pohlers D; Ondruschka B
    J Forensic Leg Med; 2018 Apr; 55():65-73. PubMed ID: 29471249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.